Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma.

Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, Salvatore G, Chiappetta G, Pacini F, Elisei R, Miccoli P, Pinchera A, Fusco A, Santoro M.

Am J Pathol. 2002 Jan;160(1):247-54.

2.

Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.

Liu RT, Chou FF, Wang CH, Lin CL, Chao FP, Chung JC, Huang CC, Wang PW, Cheng JT.

Thyroid. 2005 Apr;15(4):326-35.

PMID:
15876154
3.

RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).

Nakazawa T, Kondo T, Kobayashi Y, Takamura N, Murata S, Kameyama K, Muramatsu A, Ito K, Kobayashi M, Katoh R.

Cancer. 2005 Sep 1;104(5):943-51.

4.

Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia.

Chua EL, Wu WM, Tran KT, McCarthy SW, Lauer CS, Dubourdieu D, Packham N, O'Brien CJ, Turtle JR, Dong Q.

J Clin Endocrinol Metab. 2000 Aug;85(8):2733-9.

PMID:
10946873
5.
6.

[BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma].

Zhu XL, Zhou XY, Zhu XZ.

Zhonghua Bing Li Xue Za Zhi. 2005 May;34(5):270-4. Chinese.

PMID:
16181547
7.

Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma.

Rhoden KJ, Johnson C, Brandao G, Howe JG, Smith BR, Tallini G.

Lab Invest. 2004 Dec;84(12):1557-70.

8.

RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.

Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F.

J Clin Endocrinol Metab. 2001 Jul;86(7):3211-6.

PMID:
11443191
9.

Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus.

Smida J, Salassidis K, Hieber L, Zitzelsberger H, Kellerer AM, Demidchik EP, Negele T, Spelsberg F, Lengfelder E, Werner M, Bauchinger M.

Int J Cancer. 1999 Jan 5;80(1):32-8.

10.

Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.

Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G, Fusco A.

Oncogene. 1996 Apr 18;12(8):1821-6.

PMID:
8622903
11.

Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.

Castellone MD, Cirafici AM, De Vita G, De Falco V, Malorni L, Tallini G, Fagin JA, Fusco A, Melillo RM, Santoro M.

Oncogene. 2003 Jan 16;22(2):246-55.

PMID:
12527893
12.

RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho.

Barone MV, Sepe L, Melillo RM, Mineo A, Santelli G, Monaco C, Castellone MD, Tramontano D, Fusco A, Santoro M.

Oncogene. 2001 Oct 25;20(48):6973-82.

13.

Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.

Mechler C, Bounacer A, Suarez H, Saint Frison M, Magois C, Aillet G, Gaulier A.

Br J Cancer. 2001 Dec 14;85(12):1831-7.

14.

The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.

Melillo RM, Cirafici AM, De Falco V, Bellantoni M, Chiappetta G, Fusco A, Carlomagno F, Picascia A, Tramontano D, Tallini G, Santoro M.

Am J Pathol. 2004 Aug;165(2):511-21.

15.

RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.

Rhoden KJ, Unger K, Salvatore G, Yilmaz Y, Vovk V, Chiappetta G, Qumsiyeh MB, Rothstein JL, Fusco A, Santoro M, Zitzelsberger H, Tallini G.

J Clin Endocrinol Metab. 2006 Jun;91(6):2414-23.

PMID:
16595592
16.

[Rearrangement of the RET gene in papillary thyroid carcinoma].

Wiench M, Włoch J, Oczko M, Gubała E, Jarzab B.

Wiad Lek. 2001;54 Suppl 1:64-71. Review. Polish.

PMID:
12182064
17.

Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements.

Sheu SY, Schwertheim S, Worm K, Grabellus F, Schmid KW.

Mod Pathol. 2007 Jul;20(7):779-87.

18.

[Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].

Zhu XL, Zhou XY, Zhang TM, Zhu XZ.

Zhonghua Bing Li Xue Za Zhi. 2006 Feb;35(2):87-91. Chinese.

PMID:
16630482
19.

The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.

Powell DJ Jr, Russell J, Nibu K, Li G, Rhee E, Liao M, Goldstein M, Keane WM, Santoro M, Fusco A, Rothstein JL.

Cancer Res. 1998 Dec 1;58(23):5523-8.

20.

RET/PTC rearrangement in thyroid tumors.

Nikiforov YE.

Endocr Pathol. 2002 Spring;13(1):3-16. Review.

PMID:
12114746

Supplemental Content

Support Center